Glatopa is a generic version of Copaxone® to treat relapsing-forms of multiple sclerosis
Glatopa has been approved by the FDA as a fully substitutable version of Copaxone® (glatiramer acetate injection). Now, you can get therapeutically equivalent treatment with less financial burden.
The medicine you expect, the support you deserve
Glatopa is an FDA-approved generic that can be substituted for Copaxone®.
- Contains the same active ingredient
- Offers the same dosage therapeutic effect
- Is administered the same way (under the skin)
- Backed by GlatopaCare patient support services
Whether you are switching to Glatopa from Copaxone®, or just getting started with glatiramer acetate, you can be sure you're receiving the same FDA-approved medicine found in Copaxone®.